BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 31

• BioForest

  Vical Incorporated Presentations on TransVax(TM) and DNA Vaccines at ASGCT Conference

  May 19, 2011

   · 

  1 min read
• Business

  Takeda Pharmaceutical Co. Ltd. Nails Nycomed Buyout for $13.7 Billion, Skin Unit to Spin Off

  May 19, 2011

   · 

  7 min read
• Drug Development

  Pfizer Inc. Presents New Phase 3 Data Showing Axitinib Significantly Extended Progression-Free Survival Compared With Sorafenib In Patients With Previously-Treated Advanced Renal Cell Carcinoma

  May 19, 2011

   · 

  9 min read
• Genetown

  Celldex Therapeutics, Inc. Raises $31.5 Million

  May 19, 2011

   · 

  1 min read
• Business

  PSS World Medicall Announces Financial Goals for Fiscal Year 2012 and Three-Year Goals for FY12 To FY14

  May 19, 2011

   · 

  1 min read
• Business

  David M. Kendall, M.D., Named Distinguished Medical Fellow at Eli Lilly and Company

  May 19, 2011

   · 

  3 min read
• BioMidwest

  Eli Lilly and Company Presents Data on Cixutumumab in Five Subtypes of Sarcoma at American Society of Clinical Oncology

  May 19, 2011

   · 

  7 min read
• BioMidwest

  Study Determined Best Dose and Showed 55 Percent Response Rate With Eli Lilly and Company Anti-BAFF Monoclonal Antibody in Previously-Treated Multiple Myeloma Patients

  May 19, 2011

   · 

  4 min read